Page last updated: 2024-09-04

rhodioloside and Nasopharyngeal Neoplasms

rhodioloside has been researched along with Nasopharyngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Li, Y; Li, Z; Liu, S	1

Other Studies

1 other study(ies) available for rhodioloside and Nasopharyngeal Neoplasms

Article	Year
Salidroside suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis. Cell cycle (Georgetown, Tex.), 2022, Volume: 21, Issue:7 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Mice; Mice, Nude; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phenols	2022

Article

Year

Salidroside suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis.

Cell cycle (Georgetown, Tex.), 2022, Volume: 21, Issue:7

Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Mice; Mice, Nude; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phenols

2022